Opendata, web and dolomites
H2020 projects about "neurodegeneration"
The page lists 115 projects related to the topic "neurodegeneration".
| # | |||
|---|---|---|---|
| 1 | CorticALS | Amyotrophic Lateral Sclerosis from a cortical perspective: towards alternative therapeutic strategies | 2015 |
| 2 | ECMED | The Extracellular Matrix in Epileptogenesis | 2015 |
| 3 | JPco-fuND | ERA-NET for establishing synergies between the Joint Programming on Neurodegenerative Diseases Research and Horizon 2020 | 2015 |
| 4 | MitSyn | Alpha-synuclein and mitochondrial dysfunction: key links between Gaucher’s disease and Parkinson’s? | 2015 |
| 5 | CircaDopamine | The Role of Dopamine in the Regulation of Sleep and Circadian Rhythms | 2015 |
| 6 | STOPAPCG1IMP | Spatial-temporal regulation of APC/C, its role on G1 arrest and impact on terminal differentiation | 2015 |
| 7 | NeuroUTR | Systematic investigation of the functional coupling between transcriptional and post-transcriptional regulatory interactions underlying tissue-specific 3'UTRs variability. | 2015 |
| 8 | HEALTHYSYNAPSES | Molecular mechanisms underlying synaptic maintenance and rejuvenation | 2016 |
| 9 | RECOLOR | Regulation and consequences of LRRK2 phosphorylation,a path to Parkinson’s disease therapy and diagnostics | 2015 |
| 10 | eADAM | Ultra-small electrochemical aptasensors for specific dopamine real-time monitoring | 2016 |
| 11 | ROSNPD | Selective vulnerability of neuronal degeneration in Parkinson’s disease: the load of routine behaviour | 2016 |
| 12 | Bio4Med | International Doctoral Programme in Biological Bases of Human Diseases | 2015 |
| 13 | lincSAFARI | Sequence and Function Relationships in Long Intervening Noncoding RNAs | 2015 |
| 14 | C9ND | C9orf72-mediated neurodegeneration: mechanisms and therapeutics | 2015 |
| 15 | Dementia | DNA rEpair impaired Mice with accElerated Neurodegeneration as Tool to Improve Alzheimer therapeutics | 2015 |
| 16 | AutoRecon | Molecular mechanisms of autophagosome formation during selective autophagy | 2016 |
| 17 | MetAGEn | Metabolic and Genetic Regulation of Ageing | 2015 |
| 18 | UPR NEURO | The Unfolded Protein Response in Neurodegeneration | 2015 |
| 19 | RobustSynapses | Maintaining synaptic function for a healthy brain: Membrane trafficking and autophagy in neurodegeneration | 2016 |
| 20 | THYRAGE | Resetting the THYRoid axis for prevention of AGE-related diseases and co-morbidities | 2016 |
| 21 | SysMedPD | Systems Medicine of Mitochondrial Parkinson’s Disease | 2015 |
| 22 | IFNBetaMito | Role of IFN-β in mitochondrial homeostasis and impact on Parkinson Disease | 2016 |
| 23 | NANOZ-ONIC | Bio-inspired electrONIC NOSE interfacing olfactory electrical biosensors and carbon NANOtubes | 2016 |
| 24 | IdrSeq | Discovery and characterization of functional disordered regions and the genes involved in their regulation through next generation sequencing | 2016 |
| 25 | DELMIT | Maintaining the Human Mitochondrial Genome | 2016 |
| 26 | SynapticMitochondria | Quality Control and Maintenance of Synaptic Mitochondria | 2016 |
| 27 | SIDSCA | Defective DNA Damage Responses in Dominant Neurodegenerative Diseases | 2016 |
| 28 | IMMUNOALZHEIMER | The role of immune cells in Alzheimer's disease | 2016 |
| 29 | iPSCAtaxia | An induced pluripotent stem cell-based neuronal model of Spinocerebellar ataxia | 2016 |
| 30 | LYSOSOMICS | Functional Genomics of the Lysosome | 2016 |
| 31 | ALZSYN | Imaging synaptic contributors to dementia | 2016 |
| 32 | ALS-Networks | Defining functional networks of genetic causes for ALS and related neurodegenerative disorders | 2017 |
| 33 | MANNA | MacroAutophagy and Necrotic Neurodegeneration in Ageing | 2017 |
| 34 | URBACH-ALZ | Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala | 2017 |
| 35 | MitoMethylome | Mitochondrial methylation and its role in health and disease | 2017 |
| 36 | ArrestAD | 3-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration | 2017 |
| 37 | Keep Control | Industrial Academic Initial Training Network towards specific diagnosis and treatment of age-related gait and balance deficits | 2017 |
| 38 | DynamicBrainStates | Monitoring changes in brain states using dynamical causal networks | 2017 |
| 39 | NeuronAgeScreen | A Drug Discovery and Target Identification Screening Platform for Age-Associated Neurodegenerative Disorders | 2017 |
| 40 | ConCorND | Connectivity Correlate of Molecular Pathology in Neurodegeneration | 2017 |
| 41 | CoALIVE | Coenzyme A – Launch of In Vivo Experiments | 2017 |
| 42 | OMICS | Origami-based Microfluidic Interface for Cell Signalling | 2017 |
| 43 | PRIMASKOTI | PReparing Introduction to MArket of SKOTI (PRIMASKOTI) - a breakthrough solution for real-time studies of cytoskeletal motors at single-molecule resolution | 2017 |
| 44 | AMYPAD | Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 | 2016 |
| 45 | PHAGO | Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 | 2016 |
| 46 | NeuroTRACK | Tracking and predicting neurodegeneration spreading across the brain connectome | 2017 |
| 47 | funcSOFI-PD | Quantitative super-resolution optical fluctuation and phase microscopy for structural and functional imaging of Parkinson's disease | 2017 |
| 48 | DUBs26S | Role of a novel proteasome-associated DUB – A boon for therapeutics | 2017 |
| 49 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 50 | UbiCODE | European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets | 2018 |
| 51 | Dam2Age | DNA Damage and Repair and its Impact on Healthy Ageing | 2017 |
| 52 | DIDO-MS | Commercialization of a first in class multiple sclerosis drug | 2018 |
| 53 | RESTORE | NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION | 2018 |
| 54 | UBIQUITON | Development of a tool kit to investigate protein ubiquitylation in biomedical research | 2018 |
| 55 | Alpha-Synuclein | Blocking the prion-like disease propagation in Parkinson’s disease and related disorders – model development and identification of cell-autonomous and cell non-autonomous factors. | 2019 |
| 56 | DNAProteinCrossRep | Identification of DNA-Protein-Crosslink Repair Factors | 2018 |
| 57 | ATG9_SOLVES_IT | In vitro high resolution reconstitution of autophagosome nucleation and expansion catalyzed byATG9 | 2018 |
| 58 | MuSeq | Defining the Oligodendrocyte Lineage in Multiple Sclerosis Lesions by Single Cell RNA-Sequencing | 2018 |
| 59 | TOLKEDA | Modulating brain structural plasticity versus neurodegeneration via a novel mechanism involving neurotrophins and dopamine, Tolls and Kek truncated-Trk-like receptors in Drosophila. | 2018 |
| 60 | SinMolTermination | Single-molecule visualisation of eukaryotic DNA replication termination to uncover novel mechanisms of replication stress | 2019 |
| 61 | NMRSIGN | NMR insights on the soluble Guanylyl Cyclase conformational dynamics to illuminate the SIGNaling pathway | 2018 |
| 62 | rDNAstress | Novel insights into DNA damage and stress responses in the nucleolus: Mechanisms and relevance for genomic (in)stability and cancer | 2019 |
| 63 | PathAutoBIO | Uncovering the pathway of DNA-induced autophagy and its biological functions in viral central nervous system infection | 2018 |
| 64 | RET PHOTOSWITCH | THE DEVELOPMENT OF NOVEL PHOTOSWITCHABLE KINASE INHIBITORS | 2018 |
| 65 | NEVULA | Understanding selective neuronal vulnerability in Alzheimer’s disease | 2018 |
| 66 | NeuroRBP | Studying RNA-binding proteins involved in neural differentiation and degeneration | 2019 |
| 67 | Gut_Fights_PD | Investigating protective mechanisms of gut bacteria in C. elegans models of Parkinson’s disease | 2019 |
| 68 | TRIM-NET | Training network in drug discovery targeting TRIM Ubiquitin ligases in disease | 2019 |
| 69 | Treat-HSP | Development of new therapy for rare motor neuron diseases | 2018 |
| 70 | aDDRess | Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response | 2019 |
| 71 | MOAB | Miniaturised optically accessible bioreactor for drug discovery and biological research | 2018 |
| 72 | REMIND | Targeting pathological synaptic pruning by microglia in neurodegeneration | 2019 |
| 73 | C-MORPH | Noninvasive cell specific morphometry in neuroinflammation and degeneration | 2018 |
| 74 | SPW | Soundproof Walls | 2018 |
| 75 | JPCOFUND2 | ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND) | 2019 |
| 76 | IM2PACT | Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain | 2019 |
| 77 | LIMBo | Zooming the link between diet and brain health: how phenolic metabolites modulate brain inflammation | 2019 |
| 78 | SOLID | Suppression of Organelle Defects in Human Disease | 2019 |
| 79 | Neurovulnerability | Molecular mechanisms underlying selective neuronal death in motor neuron diseases | 2019 |
| 80 | MADEFUN | Regulation of Brain Macrophage Development and Function | 2019 |
| 81 | ChaperoneRegulome | ChaperoneRegulome: Understanding cell-type-specificity of chaperone regulation | 2020 |
| 82 | ReMyelin | The Cell Biology of Remyelination | 2019 |
| 83 | UbiGolD | Deciphering ubiquitin-dependent regulation of Golgi homeostasis control in neurodegeneration | 2019 |
| 84 | PARNANT | Pathogenetic pathways in age-related neurodegenerations as novel therapeutic targets for Parkinson’s disease | 2019 |
| 85 | NEURONET | Efficiently Networking European Neurodegeneration Research | 2019 |
| 86 | STOICISM | Stochastic Communication Inside Cortical Microcolumns | 2019 |
| 87 | Prion Respiration | The Role of Complex I Assembly Factors during Prion Diseases: Insights into Mitochondrial Neurobiology | 2019 |
| 88 | THERAPE | Novel blood-brain barrier permeable CDNF-derived therapeutic peptides for the protection and regeneration of dopamine neurons | 2019 |
| 89 | MitoQuant | Development of Deep-UV Quantitative Microscopy for the Study of Mitochondrial Dysfunction | 2019 |
| 90 | DIVE into AD | Study of tau strains to understand the phenotypic diversity of Alzheimer’s disease: A step toward personalized therapies | 2020 |
| 91 | MacMeninges | Control of Central Nervous Sytem inflammation by meningeal macrophages, and its impairment upon aging | 2019 |
| 92 | INNERVATE | Investigating the functional impact of neurodegeneration-causing rare variants in the teleost model zebrafish | 2020 |
| 93 | BreakingBarriers | Targeting endothelial barriers to combat disease | 2019 |
| 94 | MitoCRISTAE | Mitochondrial Cristae Biogenesis | 2019 |
| 95 | RetinDR | RetinDR: The first topical ophthalmic formulation (eye drops) that effectively prevents and/or treats the retinal neurodegeneration induced by diabetes (diabetic retinopathy) and/or aging | 2019 |
| 96 | TubInTrain | Tuning Tubulin Dynamics and Interactions to Face Neurotoxicity: a Multidisciplinary Approach for Training and Research | 2019 |
| 97 | FUELING-TRANSPORT | Deciphering the Role of Huntingtin in Energy Supply for Axonal Transport in Health and Huntington’s Disease | 2020 |
| 98 | SAND | Secretion, Autophagy and their role in Neurodegeneration | 2019 |
| 99 | NEUREKA | A smart, hybrid neural-computo device for drug discovery | 2019 |
| 100 | ADAMtx | ADAMtx: Development of Alzheimer’s immunotherapy by harnessing the natural reparative properties of microglia | 2019 |
| 101 | SweetBrain | A new perspective on the metabolic pathway to neuronal dysfunction: Using organs on a chip to elucidate the role of the brain microvasculature | 2020 |
| 102 | InflaCare | An exosome-based therapeutic approach against chronic inflammation | 2020 |
| 103 | NeuroPa | Targeting the brain sigma-1 receptor: A paradigm shift for the treatment of neuro-degenerative disorders | 2019 |
| 104 | RECOGNISED | Retinal and cognitive dysfunction in type 2 diabetes: unraveling the common pathways and identification of patients at risk of dementia | 2020 |
| 105 | InflaPML | Promyelocytic leukemia protein (PML) outside the tumor: a new player in the control of inflammation | 2020 |
| 106 | BIND | Brain Involvement iN Dystrophinopathies | 2020 |
| 107 | EpigeneticScars | Understanding DSB repair from pathway choice to long term effects and their consequences. | 2020 |
| 108 | MAGNIFISCENT | mesoscale multi-mode MRI of molecular targets | 2020 |
| 109 | MemDense | Cellular control of membrane protein density in the endoplasmic reticulum via the unfolded protein response | 2020 |
| 110 | NanoGlia | Understanding the impact of nanoplastics on the development of neurological disorders | 2020 |
| 111 | CTS-TEs-ADprogress | Cell type-specific molecular analysis of epigenetic changes and transposable element derepression in Alzheimer's disease progression | 2020 |
| 112 | ASTRA | ASsembly and phase Transitions of Ribonucleoprotein Aggregates in neurons: from physiology to pathology. | 2020 |
| 113 | SUPD | Sizing Up PD: Cavity-enhanced Characterisation of Single Biomarkers in Human Biofluids | 2020 |
| 114 | LySyT | Understanding the role of lysosomes in the intercellular TNT-mediated spreading of α-synuclein and the impact of lysosomal dysfunction | 2020 |
| 115 | Ctrl-BBB | Blood-brain barrier: from molecular mechanisms to intervention strategies | 2020 |